This knowledge paved the way for the development of selective inhibitors.
Our approach involved using a number of selective inhibitors for various signaling pathway.
Both non-selective and selective inhibitors of the enzyme have been described.
On the other hand, selective serotonin reuptake inhibitors are not useful.
N-domain selective inhibitors on the other hand give the possibility of opening up novel therapeutic areas.
In 1995, betulinic acid was reported as a selective inhibitor of human melanoma.
A recent case report suggests selective serotonin reuptake inhibitors may be helpful.
"Most of the antidepressant drugs in use these days are selective serotonin reuptake inhibitors, for example."
Identification of features common to the most selective inhibitors has led to a "five-point model" with:
Selective serotonin reuptake inhibitors are used to treat depression and anxiety.
